Inozyme Pharma Overview
Inozyme Pharma Discounted Cash Flow
DCF Analysis for INZY.
Get informed when a big investor buys or sells
+ FollowFair Value
$-0.41
Current Fair Value
$-0.41
↓ 110.3% Downside
Overvalued by 110.3% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison